Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Eisinger, US
Darren P. Eisinger, Columbus, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20120054989 | WEB ADJUSTER FOR VEHICLE SEAT HARNESS - A child-restraint system is adapted for use with a juvenile vehicle seat. The child-restraint system includes a frame configured to be mounted on the juvenile vehicle seat and a web clamp coupled to the frame. The web clamp is configured to clamp a web passing under the web clamp and through a web-receiving channel formed in the frame. | 03-08-2012 |
Dominic Eisinger, Keene, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110065137 | Methods and Devices for Detecting Obstructive Uropathy and Associated Disorders - Methods and devices for diagnosing, monitoring, or determining obstructive uropathy or an associated disorder in a mammal are described. In particular, methods and devices for diagnosing, monitoring, or determining obstructive uropathy or an associated disorder using measured concentrations of a combination of three or more analytes in a test sample taken from the mammal are described. | 03-17-2011 |
| 20110065593 | Computer Methods and Devices for Detecting Kidney Damage - Methods and devices for diagnosing, monitoring, or determining a renal disorder in a mammal are described. In particular, methods and devices for diagnosing, monitoring, or determining a renal disorder using measured concentrations of a combination of three or more analytes in a test sample taken from the mammal are described. | 03-17-2011 |
| 20110065598 | Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders - Methods and devices for diagnosing, monitoring, or determining diabetic nephropathy or an associated disorder in a mammal are described. In particular, methods and devices for diagnosing, monitoring, or determining diabetic nephropathy or an associated disorder using measured concentrations of a combination of three or more analytes in a test sample taken from the mammal are described. | 03-17-2011 |
| 20110065599 | Methods and Devices for Detecting Kidney Damage - Methods and devices for diagnosing, monitoring, or determining kidney damage in a mammal are described. In particular, methods and devices for diagnosing, monitoring, or determining kidney damage using measured concentrations of a combination of three or more analytes in a test sample taken from the mammal are described. | 03-17-2011 |
Dominic P. Eisinger, Keene, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110065136 | Methods and Devices for Detecting Glomerulonephritis and Associated Disorders - Methods and devices for diagnosing, monitoring, or determining glomerulonephritis or an associated disorder in a mammal are described. In particular, methods and devices for diagnosing, monitoring, or determining glomerulonephritis or an associated disorder using measured concentrations of a combination of three or more analytes in a test sample taken from the mammal are described. | 03-17-2011 |
| 20110065608 | Devices for Detecting Renal Disorders - Devices for diagnosing, monitoring, or determining a renal disorder in a mammal are described. In particular, devices for diagnosing, monitoring, or determining a renal disorder using measured concentrations of a combination of three or more analytes in a test sample taken from the mammal are described. | 03-17-2011 |
| 20110177959 | Methods and Devices for Detecting Kidney Transplant Rejection - Methods and devices for diagnosing, monitoring, or determining kidney transplant rejection or an associated disorder in a mammal are described. In particular, methods and devices for diagnosing, monitoring, or determining kidney transplant rejection or an associated disorder using measured concentrations of a combination of three or more analytes in a test sample taken from the mammal are described. | 07-21-2011 |
George E. Eisinger, Scottsdale, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20100023083 | METHODS AND DEVICES INVOLVING AUTOMATIC ATRIAL BLANKING - During a period of time comprising a plurality of cardiac cycles, a time relationship between ventricular events and atrial detections is established. Based on the relationship, a post-ventricular atrial refractory period is defined. The period includes an absolute atrial refractory period and a segmented relative atrial refractory period, wherein the segmented relative atrial refractory period includes at least one blanking window during which atrial detections of ventricular events have or are likely to occur. | 01-28-2010 |
Jacob Daniel Eisinger, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20090031336 | GROUP PREFERENCE CONTROL SYSTEM - A method, medium and implementing computer system are provided in which the aggregate preferences of a gathered group of individuals in a certain proximity and with respect to a predetermined perceivable and controllable function are ascertained. Individual preferences are processed to obtain a group preference and if the group preference meets predetermined criteria, the group preference is implemented with respect to the controllable function. In a specific example, movie preview playlists are modified by a control server according to the ascertained preferences of the particular group to whom the movie previews are being presented. In another example, the ambient temperature of a room in which a group of individuals is gathered is adjusted by a temperature-control server in response to the polled and ascertained preferences of each of the individuals. | 01-29-2009 |
| 20090129596 | System and Method for Controlling Comments in a Collaborative Document - A system, method, and program product is provided that operates when opening a word processing document that includes document content inserted at various insertion points within the document. The document is opened by a user that corresponds to a particular user identifier. The comments included in the document include recipient identifiers. A first set of comments are selected where the user's identifier is included in the recipient identifiers of the corresponding comments, and a second set of comments are selected where the user's identifier is not included in the recipient identifiers of the corresponding comments. The word processor displays the first set of comments at their respective insertion points within the document content and does not present the second set of comments. | 05-21-2009 |
Magdalena Eisinger, Demarest, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090215902 | METHODS FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS - The present invention is directed to the use of a compound of formula (I) | 08-27-2009 |
| 20100280079 | 0NOVEL, 1,2,4-THIADIAZOLIUM DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS - The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder. | 11-04-2010 |
Magdalena Eisinger Eisinger, Demarest, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090203751 | Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators - The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder. | 08-13-2009 |